IE 11 is a very old browser and is not supported on this site.

Annual Report 2023


Galenica Group sales performed well in 2023, growing 4.4% to CHF 3,746.0 million. The adjusted1 EBIT increased slightly to CHF 191.3 million.

Milestones 2023
January Verfora acquires Padma Ltd.: With the acquisition, Verfora expands its complementary medicine portfolio and supplements its range of reimbursable medicines.
February Aid for earthquake victims in Turkey/Syria: We are saddened about the fate of these people. Galenica doubles employees’ private donations to Swiss Solidarity.
March The new Galenica branding is launched: Inspired by the network concept, the new corporate design, with the logo as its focal point, serves primarily as a symbol of a new beginning and transformation.
April Leading online pharmacy in Switzerland: Switzerland's leading online pharmacy is created in a joint venture under the name Mediservice. Redcare will hold 51% and Galenica 49%.
May Rebranding of Sun Store pharmacies in German-speaking Switzerland: The ten Sun Store pharmacies in German-speaking Switzerland are being transferred to the Amavita world. This generates synergies, particularly in the marketing area.
June Galenica acquires 16% stake in AD Swiss Net Ltd.: With “BENECURA public”, we further advance integrated and networked healthcare in Switzerland.
July High-ranking visit to Padma: With the visit of His Holiness Sakya Trizin, head of the Sakya School of Tibetan Buddhism, and the third-ranking Tibetan Lama, Padma experiences a rare highlight.
August Ambassador visits Galexis: As part of the FDFA Ambassadors’ Conference, a group of ambassadors visits the Galexis site in Niederbipp.
September New Head of People & Culture: Arianne Hasler joins Galenica as Head of the People & Culture Service Unit (formerly Human Resources) and becomes a member of the Executive Committee.
October Opinio employee survey – only online for the first time: The online survey is conducted from 17 October to 15 November. A participation rate of 72% and the new employee recommendation rate of 76, which has increased by two points, are gratifying.
November Opening of the Amavita pharmacy at the main station in Zurich: After a three-year renovation phase, the team of the Amavita Bahnhof Apotheke located at Zurich main station is able to welcome its customers back to its original location in renovated and redesigned premises.
December Joint venture with Planzer: The new company, called Health Supply Ltd., aims to make the transportation of medicines and other products to healthcare providers more efficient and sustainable.

Our key figures

With its Annual Report 2023, Galenica publishes a combined annual and sustainability report based on the GRI standard with full annual economic, social and environmental data.

Financial key figures


Net sales
in million CHF


EBIT adjusted

in million CHF



in CHF per share

Key social figures


Number of employees

as of 31.12.2023


Investment in employee development

in million CHF


Availability of medicinal products

on average 2023

Key environmental figures


Energy consumption

from renewable sources


Energy intensity

in MWh/FTE


Waste is recycled

on average 2023


“The healthcare services in our pharmacies not only meet customer needs, they also help to curb the increasing cost pressure in the healthcare sector.”

Management report

Galenica continues to grow in financial year 2023

The Galenica Group achieved strong growth with an increase in sales of 4.4% in the 2023 financial year and generated consolidated net sales of CHF 3,746.0 million. Adjusted for the extraordinary sales related to COVID-19 (self-tests, COVID vaccinations and rapid tests) in the prior-year period, growth amounted to a substantial 5.0%. Despite special effects in the amount of CHF 9.8 million, adjusted1 EBIT increased by 0.4% to CHF 191.3 million. Adjusted for these special effects, adjusted1 EBIT would have increased by 5.5% to CHF 201.1 million.


Great progress in sustainability

We firmly believe that our Group can achieve long-term commercial success only if we also bear responsibility for society and use natural resources sparingly and efficiently. In the 2023 financial year, Galenica continued to implement concrete measures to achieve the sustainability goals formulated in 2021.


We are the largest health network in Switzerland and play an important role in the healthcare market. We want to sustainably and successfully strengthen our market position and further develop our core competences.



Our patients and customers are at the heart of what we do. And this is at the core of our customer promise: “We support people at every stage of life on their journey towards health and well-being.”


Business Development

Galenica’s strategic programmes are focused on offering customers and patients the best customer experience across all channels.



The Galenica Group support its employees to develop their skills and realise their full potential – also with the aim of being an attractive employer and attracting and retaining valuable specialists.

Galenica Story

Our vision, values and customer promise set out what drives us, how we work and what we offer. The strategic programmes define what we want to achieve, and how.

Galenica uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. Use of cookies & disclaimer